Drug release rate influences the pharmacokinetics, biodistribution, therapeutic activity, and toxicity of pegylated liposomal doxorubicin formulations in murine breast cancer

Biochimica et Biophysica Acta - Biomembranes

Volumn 1663, Issue 1-2, 2004, Pages 167-177

  Charrois, Gregory J R ^a   Allen, Theresa M ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Biodistribution; Breast cancer; Cmax; CHOL; cholesterol; dimyristoylphosphatidylcholine; dioleoylphosphatidylcholine; DMPC; DOPC; Drug release rate; DSPC; maximal tissue concentration; Pegylated liposomal doxorubicin; Pharmacokinetic

Indexed keywords

DOXORUBICIN; LIPOSOME; PHOSPHATIDYLCHOLINE; STEALTH;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG DISTRIBUTION; DRUG EFFECT; DRUG FORMULATION; DRUG RELEASE; FEMALE; FLUIDIZATION; HAND FOOT SYNDROME; LIPID BILAYER; LIPID COMPOSITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN CULTURE; SLOW RELEASE FORMULATION;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; AREA UNDER CURVE; BREAST NEOPLASMS; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; DOXORUBICIN; FEMALE; HALF-LIFE; INJECTIONS, INTRAVENOUS; LIPOSOMES; MICE; MICE, INBRED BALB C; NEOPLASM TRANSPLANTATION; PHOSPHATIDYLCHOLINES; POLYETHYLENE GLYCOLS; TISSUE DISTRIBUTION; TRANSITION TEMPERATURE;

MURINAE;

EID: 2442551191     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamem.2004.03.006     Document Type: Article

References (44)

1. Mayer L.D., Tai L.C., Ko D.S., Masin D., Ginsberg R.S., Cullis P.R., Bally M.B. Cancer Res. 49:1989;5922-5930
2. Bally M.B., Nayar R., Masin D., Cullis P.R., Mayer L.D. Cancer Chemother. Pharmacol. 27:1990;13-19
3. Allen T.M., Mehra T., Hansen C.B., Chin Y.C. Cancer Res. 52:1992;2431-2439
4. Drummond D.C., Meyer O., Hong K.L., Kirpotin D.B., Papahadjopoulos D. Pharmacol. Rev. 51:1999;691-743
5. Waterhouse D.N., Tardi P.G., Mayer L.D., Bally M.B. Drug Safety. 24:2001;903-920
6. Working P., Dayan A.D. Human Exp. Toxicol. 15:1996;751-785
7. Cowens J.W., Creaven P.J., Greco W.R., Brenner D.E., Tung Y., Osto M., Pilkiewicz F., Ginsberg R., Petrelli N. Cancer Res. 53:1993;2796-2802
8. Gabizon A., Catane R., Uziely B., Kaufman B., Safra T., Cohen R., Martin F., Huang A., Barenholz Y. Cancer Res. 54:1994;987-992
9. Berry G., Billingham M., Alderman E., Richardson P., Torti F., Lum B., Patek A., Martin F.J. Ann. Oncol. 9:1998;711-716
10. Batist G., Ramakrishnan G., Rao C.S., Chandrasekharan A., Gutheil J., Guthrie T., Shah P., Khojasteh A., Nair M.K., Hoelzer K., Tkaczuk K., Park Y.C., Lee L.W. J. Clin. Oncol. 19:2001;1444-1454
11. Uziely B., Jeffers S., Isacson R., Kutsch K., Wei-Tsao D., Yehoshua Z., Libson E., Muggia F.M., Gabizon A. J. Clin. Oncol. 13:1995;1777-1785
12. Ranson M.R., Carmichael J., O'Byrne K., Stewart S., Smith D., Howell A. J. Clin. Oncol. 15:1997;3185-3191
13. Muggia F., Hainsworth J.D., Jeffers S., Miller P., Groshen S., Tan M., Roman L., Uziely B., Muderspach L., Garcia A., Burnett A., Greco F.A., Morrow C.P., Paradiso L.J., Liang L.-J. J. Clin. Oncol. 15:1997;987-993
14. Lotem M., Hubert A., Lyass O., Goldenhersh M.A., Ingber A., Peretz T., Gabizon A. Arch. Dermatol. 136:2000;1474-1480
15. Lopez A.M., Wallace L., Dorr R.T., Koff M., Hersh E.M., Alberts D.S. Cancer Chemother. Pharmacol. 44:1999;303-306
16. Remlinger K.A. Arch. Dermatol. 139:2003;77-81
17. Allen T.M., Hansen C.B., Lopes de Menezes D.E. Adv. Drug Deliv. Rev. 16:1995;267-284
18. Hashizume H., Baluk P., Morikawa S., McLean J.W., Thurston G., Roberge S., Jain R.K., McDonald D.M. Am. J. Pathol. 156:2000;1363-1380
19. Maeda H., Wu J., Sawa T., Matsumura Y., Hori K. J. Control. Release. 65:2000;271-284
20. Papahadjopoulos D., Allen T.M., Gabizon A., Mayhew E., Matthay K., Huang S.K., Lee K.D., Woodle M.C., Lasic D.D., Redemann C., Martin F.J. Proc. Natl. Acad. Sci. U. S. A. 88:1991;11460-11464
21. Gabizon A.A. Cancer Res. 52:1992;891-896
22. Gabizon A., Papahadjopoulos D. Proc. Natl. Acad. Sci. U. S. A. 85:1988;6949
23. Allen T.M., Hansen C., Rutledge J. Biochim. Biophys. Acta. 981:1989;27-35
24. Allen T.M., Hansen C.B., Martin F., Redemann C., Yau-Young A. Biochim. Biophys. Acta. 1066:1991;29-36
25. Gabizon A., Goren D., Horowitz A.T., Tzemach D., Lossos A., Siegal T. Adv. Drug Deliv. Rev. 24:1997;337-344
26. Charrois G.J.R., Allen T.M. Biochim. Biophys. Acta. 1609:2003;102-108
27. Allen T.M., Cleland L.G. Biochim. Biophys. Acta. 597:1980;418-426
28. Gabizon A.A., Barenholz Y., Bialer M. Pharm. Res. 10:1993;703-708
29. Mayer L.D., Hope M.J., Cullis P.R. Biochim. Biophys. Acta. 858:1986;161-168
30. Bolotin E.M., Cohen R., Bar L.K., Emanuel S.N., Lasic D.D., Barenholz Y. J. Liposome Res. 4:1994;455-479
31. Lim H.J., Masin D., Madden T.D., Bally M.B. J. Pharmacol. Exp. Ther. 281:1997;566-573
32. Aslakson C.J., Miller F.R. Cancer Res. 52:1992;1399-1405
33. Moase E., Qi W., Ishida T., Gabos Z., Longenecker B.M., Zimmermann G.L., Ding L., Krantz M., Allen T.M. Biochim. Biophys. Acta. 1510:2001;43-55
34. Shargel L., Yu A.B.C. Applied Biopharmaceutics and Pharmacokinetics. 4th ed. 1999;McGraw Hill, New York
35. Harasym T.O., Cullis P.R., Balley M.B. Cancer Chemother. Pharmacol. 40:1997;309-317
36. Gabizon A., Shiota R., Papahadjopoulos D. J. Natl. Cancer Inst. 81:1989;1484-1488
37. Charrois G.J.R., Allen T.M. J. Pharm. Exp. Ther. 306:2003;1058-1067
38. Mayer L.D., Bally M.B., Loughrey H., Masin D., Cullis P.R. Cancer Res. 50:1990;575-579
39. Woodle M.C., Matthay K.K., Newman M.S., Hidayat J.E., Collins L.R., Redemann C., Martin F.J., Papahadjopoulos D. Biochim. Biophys. Acta. 1105:1992;193-200
40. Derksen J.T., Morselt H.W., Scherphof G.L. Biochim. Biophys. Acta. 931:1987;33-40
41. Sommerman E.F., Pritchard P.H., Cullis P.R. Biochem. Biophys. Res. Commun. 122:1984;319-324
42. Gabizon A., Huberty J., Straubinger R.M., Price D.C., Papahadjopoulos D. J. Liposome Res. 1:1989;123-135
43. Bandak S., Goren D., Horowitz A., Tzemach D., Gabizon A. Anticancer Drugs. 10:1999;911-920
44. Kim E.S., Lu C., Khuri F.R., Tonda M., Glisson B.S., Liu D., Jung M., Hong W.K., Herbst R.S. Lung Cancer. 34:2001;427-432